4D Molecular Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3.0M | 85.1M | 90K | 15K | 14K | 1K | 3K | 5K |
| Cost of Goods Sold | 2.1M | 2.0M | 47.2M | 48.0M | 40.7M | 1.8M | 38.5M | 31.9M |
| Gross Profit | 992K | 83.1M | -47.1M | -47.9M | -40.7M | -1.8M | -38.5M | -31.9M |
| R&D Expenses | 65.0M | 57.6M | 49.4M | 48.0M | 40.7M | 43.1M | 38.5M | 31.9M |
| Operating Expenses | 74.6M | 68.4M | 14.0M | 11.5M | 12.9M | 54.3M | 12.7M | 10.6M |
| Operating Income | -73.6M | 14.7M | -61.2M | -59.5M | -53.6M | -56.1M | -51.1M | -42.5M |
| Other Income / Gains | 4.9M | 4.7M | 4.3M | 4.8M | 5.6M | 6.4M | 7.3M | 7.5M |
| Net Income | -68.8M | 19.4M | -56.9M | -54.7M | -48.0M | -49.7M | -43.8M | -35.0M |
| EPS (Diluted) | -1.01 | 0.34 | -1.01 | -0.98 | -0.86 | -0.90 | -0.79 | -0.63 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.326 | 0.977 | -523.867 | -3K | -3K | -2K | -13K | -6K |
| General And Administrative Expenses | 11.7M | 12.8M | 11.8M | 11.5M | 12.9M | 13.0M | 12.7M | 10.6M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 1.6M | 0 | 0 |
| Selling General And Administrative Expenses | 11.7M | 12.8M | 11.8M | 11.5M | 12.9M | 14.6M | 12.7M | 10.6M |
| Other Expenses | -2.1M | -2.0M | -47.2M | -48.0M | -40.7M | -3.4M | -38.5M | -31.9M |
| Cost And Expenses | 76.7M | 70.4M | 61.3M | 59.5M | 53.6M | 56.1M | 51.1M | 42.5M |
| Interest Income | 4.9M | 4.7M | 4.3M | 4.9M | 5.6M | 6.5M | 7.3M | 7.5M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 2.1M | 2.0M | 1.3M | 1.2M | 1.8M | 1.8M | 1.7M | 1.2M |
| Ebitda | -66.7M | 12.4M | -55.6M | -53.5M | -46.2M | -47.9M | -42.1M | -33.8M |
| Ebitdaratio | -21.892 | 0.146 | -617.944 | -4K | -3K | -48K | -14K | -7K |
| Operating Income Ratio | -24.161 | 0.173 | -679.833 | -4K | -4K | -56K | -17K | -8K |
| Income Before Tax | -68.8M | 19.4M | -56.9M | -54.7M | -48.0M | -49.7M | -43.8M | -35.0M |
| Income Before Tax Ratio | -22.566 | 0.228 | -631.956 | -4K | -3K | -50K | -15K | -7K |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -22.566 | 0.228 | -631.956 | -4K | -3K | -50K | -15K | -7K |
| Epsdiluted | -1.01 | 0.34 | -1.01 | -0.98 | -0.86 | -0.90 | -0.79 | -0.63 |
| Weighted Average Shs Out | 68.1M | 57.9M | 56.1M | 55.9M | 55.7M | 53.9M | 55.6M | 55.3M |
| Weighted Average Shs Out Dil | 68.1M | 57.9M | 56.1M | 55.9M | 55.7M | 53.9M | 55.6M | 55.3M |